Edwards Lifesciences Corp
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
What If You Bought EW Earlier?
Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.
Stock Split History
Newest split first. Cumulative multiple = compounded growth from that date to today.
| Split Date | Price Before | Ratio | Split Multiple | Cumulative |
|---|---|---|---|---|
| Jun 1, 2020 | $74.91 | 3-for-1 | 3× | 12× |
| Dec 14, 2015 | $26.62 | 2-for-1 | 2× | 4× |
| May 28, 2010 | $8.65 | 2-for-1 | 2× | 2× |
Edwards Lifesciences Corp Market Cap Timeline
Validated annual market-cap history is available from 2000. Split markers cover all 3 recorded splits. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.